Skip to main content
. Author manuscript; available in PMC: 2015 Mar 11.
Published in final edited form as: Anticancer Res. 2015 Mar;35(3):1263–1269.

Figure 6.

Figure 6

Western blot (A) and densitometry (n=3) (B) for survivin expression in A172 cell line where 1: control; 2: 50 μM silibinin; 3: 25 μM temozolomide; 4: 50 μM silibinin and 25 μM temozolomide; 5: 100 μM silibinin. Significance of difference between control and treatments were evaluated by a Students t-test. *=p<.05